Cargando…
Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163754/ https://www.ncbi.nlm.nih.gov/pubmed/37147731 http://dx.doi.org/10.1186/s13014-023-02245-0 |
| _version_ | 1785037949562257408 |
|---|---|
| author | Jiang, Li Zhu, Jie Chen, Xue Wang, Yi Wu, Lei Wan, Gang Han, Yongtao Leng, Xuefeng Peng, Lin Wang, Qifeng |
| author_facet | Jiang, Li Zhu, Jie Chen, Xue Wang, Yi Wu, Lei Wan, Gang Han, Yongtao Leng, Xuefeng Peng, Lin Wang, Qifeng |
| author_sort | Jiang, Li |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10163754 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101637542023-05-07 Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study Jiang, Li Zhu, Jie Chen, Xue Wang, Yi Wu, Lei Wan, Gang Han, Yongtao Leng, Xuefeng Peng, Lin Wang, Qifeng Radiat Oncol Correction BioMed Central 2023-05-05 /pmc/articles/PMC10163754/ /pubmed/37147731 http://dx.doi.org/10.1186/s13014-023-02245-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Jiang, Li Zhu, Jie Chen, Xue Wang, Yi Wu, Lei Wan, Gang Han, Yongtao Leng, Xuefeng Peng, Lin Wang, Qifeng Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study |
| title | Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study |
| title_full | Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study |
| title_fullStr | Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study |
| title_full_unstemmed | Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study |
| title_short | Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study |
| title_sort | correction to: safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163754/ https://www.ncbi.nlm.nih.gov/pubmed/37147731 http://dx.doi.org/10.1186/s13014-023-02245-0 |
| work_keys_str_mv | AT jiangli correctiontosafetyandefficacyofpaclitaxelpluscarboplatinversuspaclitaxelpluscisplatininneoadjuvantchemoradiotherapyforpatientswithlocallyadvancedesophagealcarcinomaaretrospectivestudy AT zhujie correctiontosafetyandefficacyofpaclitaxelpluscarboplatinversuspaclitaxelpluscisplatininneoadjuvantchemoradiotherapyforpatientswithlocallyadvancedesophagealcarcinomaaretrospectivestudy AT chenxue correctiontosafetyandefficacyofpaclitaxelpluscarboplatinversuspaclitaxelpluscisplatininneoadjuvantchemoradiotherapyforpatientswithlocallyadvancedesophagealcarcinomaaretrospectivestudy AT wangyi correctiontosafetyandefficacyofpaclitaxelpluscarboplatinversuspaclitaxelpluscisplatininneoadjuvantchemoradiotherapyforpatientswithlocallyadvancedesophagealcarcinomaaretrospectivestudy AT wulei correctiontosafetyandefficacyofpaclitaxelpluscarboplatinversuspaclitaxelpluscisplatininneoadjuvantchemoradiotherapyforpatientswithlocallyadvancedesophagealcarcinomaaretrospectivestudy AT wangang correctiontosafetyandefficacyofpaclitaxelpluscarboplatinversuspaclitaxelpluscisplatininneoadjuvantchemoradiotherapyforpatientswithlocallyadvancedesophagealcarcinomaaretrospectivestudy AT hanyongtao correctiontosafetyandefficacyofpaclitaxelpluscarboplatinversuspaclitaxelpluscisplatininneoadjuvantchemoradiotherapyforpatientswithlocallyadvancedesophagealcarcinomaaretrospectivestudy AT lengxuefeng correctiontosafetyandefficacyofpaclitaxelpluscarboplatinversuspaclitaxelpluscisplatininneoadjuvantchemoradiotherapyforpatientswithlocallyadvancedesophagealcarcinomaaretrospectivestudy AT penglin correctiontosafetyandefficacyofpaclitaxelpluscarboplatinversuspaclitaxelpluscisplatininneoadjuvantchemoradiotherapyforpatientswithlocallyadvancedesophagealcarcinomaaretrospectivestudy AT wangqifeng correctiontosafetyandefficacyofpaclitaxelpluscarboplatinversuspaclitaxelpluscisplatininneoadjuvantchemoradiotherapyforpatientswithlocallyadvancedesophagealcarcinomaaretrospectivestudy |